CNSP Stock: CNS Pharmaceuticals, Inc. Stock Price, Analysis & Insights
Get live cnsp stock price $6.25, comprehensive CNS Pharmaceuticals, Inc. stock analysis, charts, news, and expert forecast. Real-time cnsp stock data and investment insights.
Company Overview
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.
Company Information
- CEO
- John Michael Climaco
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 4
Contact Information
- Website
- https://www.cnspharma.com
- Address
- 2100 West Loop South
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 3.59M market capitalization
- Trading Volume: 5.37K shares traded today
- Price Range: 52-week range of $4.93 - $222.00
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. (CNSP) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 3.59M, the company represents a significant player in its market. The stock is currently trading at $6.25 with a positivedaily change of 0.81%.
The company's 4 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of N/A, beta of 0.76, and 52-week price range from $4.93 to $222.00when evaluating investment opportunities.
Why Invest in CNS Pharmaceuticals, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under John Michael Climaco
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.